These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Tiapride in the treatment of neurological and psychiatric disorders in the elderly (author's transl)]. Miletto G; Julou M Sem Hop; 1981 Nov 18-25; 57(43-44):1833-6. PubMed ID: 6274032 [TBL] [Abstract][Full Text] [Related]
4. [Use of beta-adrenergic blockers in neurologic and psychiatric clinical practice]. Obukhov GA Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(5):746-61. PubMed ID: 6115528 [No Abstract] [Full Text] [Related]
5. [Use of calcium inhibitors in neuropsychiatric pathology]. Lançon C; Valli M; Jadot G Therapie; 1990; 45(2):131-7. PubMed ID: 2191469 [TBL] [Abstract][Full Text] [Related]
6. [Estrogen and protestational hormone treatment and neuropsychiatric problems]. Pescetto G Sist Nerv; 1969; 21(6):348-62. PubMed ID: 5402451 [No Abstract] [Full Text] [Related]
7. Cholinergic-adrenergic hypothesis of mania and depression. Tarsy D; Leopold N; Sax DS Lancet; 1972 Nov; 2(7787):1153. PubMed ID: 4117233 [No Abstract] [Full Text] [Related]
8. Neuropsychiatric complications of hepatic failure. Sen S J Indian Med Assoc; 1968 Nov; 51(9):466-8. PubMed ID: 4891353 [No Abstract] [Full Text] [Related]
9. [Controlled clinical trial of dihydroergocristine in neuropsychiatric disorders in cerebrovascular insufficiency]. Muchnik S Boll Chim Farm; 1982 May; 121(5):33S-46S. PubMed ID: 6814466 [No Abstract] [Full Text] [Related]
10. [Increased knowledge of dopamine receptors results in better drugs in the treatment of neurologic and psychological disorders]. Hall H Lakartidningen; 1991 Aug; 88(35):2761-5. PubMed ID: 1895826 [No Abstract] [Full Text] [Related]
11. Caution on the potential usefulness of statins in neuropsychiatric diseases. Brondino N; Emanuele E; Geroldi D Med Hypotheses; 2007; 69(3):697. PubMed ID: 17350766 [No Abstract] [Full Text] [Related]
13. [The world of serotonin and its receptors. Physiopathologic, clinical, and therapeutic aspects]. Marco Igual M Med Clin (Barc); 1993 Jun; 101(4):144-53. PubMed ID: 8355545 [No Abstract] [Full Text] [Related]
14. The nitric oxide pathway: potential implications for treatment of neuropsychiatric disorders. Karatinos J; Rosse RB; Deutsch SI Clin Neuropharmacol; 1995 Dec; 18(6):482-99. PubMed ID: 8681310 [TBL] [Abstract][Full Text] [Related]
15. Testosterone replacement therapy for the treatment of neurological and neuropsychiatric disorders. Gold SM; Voskuhl RR Curr Opin Investig Drugs; 2006 Jul; 7(7):625-30. PubMed ID: 16869115 [TBL] [Abstract][Full Text] [Related]
16. [Neuropsychiatric symptoms and findings in systemic lupus erythematosus ]. Lund C; Gjerstad L Tidsskr Nor Laegeforen; 1997 May; 117(14):2043-5. PubMed ID: 9235685 [TBL] [Abstract][Full Text] [Related]
17. [Immunologic studies of neuropsychiatric diseases]. Semenov SF Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(4):602-5. PubMed ID: 7023157 [No Abstract] [Full Text] [Related]
18. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders. Chang L; Cloak CC; Ernst T J Clin Psychiatry; 2003; 64 Suppl 3():7-14. PubMed ID: 12662128 [TBL] [Abstract][Full Text] [Related]
19. Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Stanger O; Fowler B; Piertzik K; Huemer M; Haschke-Becher E; Semmler A; Lorenzl S; Linnebank M Expert Rev Neurother; 2009 Sep; 9(9):1393-412. PubMed ID: 19769453 [TBL] [Abstract][Full Text] [Related]
20. [Use of peptides in psychiatry and neurology (review)]. Bulaev VM Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1244-8. PubMed ID: 3314286 [No Abstract] [Full Text] [Related] [Next] [New Search]